Combination therapy of telmisartan and amlodipine provides significantly better blood pressure lowering than either agent alone

Stockholm/Sweden, 31 August 2010 - Data show that treatment with a single-pill combination of telmisartan, an angiotensin receptor blocker, (ARB) and amlodipine, a calcium channel blocker (CCB) results in significant reductions in blood pressure (BP) in patients with severe hypertension. ¹ The data, which was presented recently at 20 th Scientific Meeting of the European Society of Hypertension (ESH) in Oslo, and was discussed today at a briefing in Stockholm, also demonstrate the consistently higher BP control/response rates achieved compared to treatment with telmisartan or amlodipine treatment alone. ¹